insulin degludec
Generic: insulin degludec
Labeler: novo nordisk pharma, inc.Drug Facts
Product Profile
Brand Name
insulin degludec
Generic Name
insulin degludec
Labeler
novo nordisk pharma, inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
insulin degludec 100 U/mL
Manufacturer
Identifiers & Regulatory
Product NDC
73070-403
Product ID
73070-403_c1be283d-4b1d-4996-b2a7-4488dbff3037
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA203314
Listing Expiration
2026-12-31
Marketing Start
2022-07-01
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
73070403
Hyphenated Format
73070-403
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
insulin degludec (source: ndc)
Generic Name
insulin degludec (source: ndc)
Application Number
BLA203314 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 U/mL
Packaging
- 5 SYRINGE, PLASTIC in 1 CARTON (73070-403-15) / 3 mL in 1 SYRINGE, PLASTIC
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "c1be283d-4b1d-4996-b2a7-4488dbff3037", "openfda": {"nui": ["M0011417", "N0000175453"], "unii": ["54Q18076QB"], "rxcui": ["1670011", "1670021", "2107520"], "spl_set_id": ["c1be283d-4b1d-4996-b2a7-4488dbff3037"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Novo Nordisk Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 SYRINGE, PLASTIC in 1 CARTON (73070-403-15) / 3 mL in 1 SYRINGE, PLASTIC", "package_ndc": "73070-403-15", "marketing_start_date": "20220701"}], "brand_name": "Insulin Degludec", "product_id": "73070-403_c1be283d-4b1d-4996-b2a7-4488dbff3037", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [CS]"], "product_ndc": "73070-403", "generic_name": "insulin degludec", "labeler_name": "Novo Nordisk Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Insulin Degludec", "active_ingredients": [{"name": "INSULIN DEGLUDEC", "strength": "100 U/mL"}], "application_number": "BLA203314", "marketing_category": "BLA", "marketing_start_date": "20220701", "listing_expiration_date": "20261231"}